IL6 and diabetes mellitus: These results contrasted markedly from the findings of a previous study, in which ASCs from patients with diabetes or atherosclerosis strongly expressed pro-inflammatory markers such as IL-1β, IL6, and IL-8/CXCL8 [17, 18].